Use of adenoviral E1A protein to analyze K18 promoter deregulation in colon carcinoma cells discloses a role for CtBP1 and BRCA1

BMC Molecular Biology

Volumn 6, Issue , 2005, Pages

  Delouis, Cécile ^a   Prochasson, Philippe ^a,b   Laithier, Madeleine ^a   Brison, Olivier ^a,c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; E1A PROTEIN; HISTONE DEACETYLASE; HOLOENZYME; KERATIN; KERATIN 18; RNA POLYMERASE II; UNCLASSIFIED DRUG; ALCOHOL DEHYDROGENASE; C TERMINAL BINDING PROTEIN; C-TERMINAL BINDING PROTEIN; CYTOKERATIN 18; DNA BINDING PROTEIN; KRT18 PROTEIN, HUMAN; PHOSPHOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL CLONING; COLON CARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; DELETION MUTANT; DEREGULATION; HUMAN; HUMAN CELL; POINT MUTATION; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; TATA BOX; TRANSCRIPTION INITIATION SITE; WILD TYPE; COMPARATIVE STUDY; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PLASMID; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOVIRIDAE;

ADENOVIRUS E1A PROTEINS; ALCOHOL OXIDOREDUCTASES; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HUMANS; KERATIN-18; KERATINS; PHOSPHOPROTEINS; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION;

EID: 26444603096     PISSN: 14712199     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-6-8     Document Type: Article

References (48)

1. Gallimore PH, Turnell AS: Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 2001, 20:7824-7835.
2. Ben Israel H, Kleinberger T: Adenovirus and cell cycle control. Front Biosci 2002, 7:d1369-d1395.
3. Frisch SM, Mymryk JS: Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 2002, 3:441-452.
4. Chinnadurai G: CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 2002, 9:213-224.
5. Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G: Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A 1995, 92:10467-10471.
6. Schaeper U, Subramanian T, Lim L, Boyd JM, Chinnadurai G: Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J Biol Chem 1998, 273:8549-8552.
7. Wong AK, Ormonde PA, Pero R, Chen Y, Lian L, Salada G, Berry S, Lawrence Q, Dayananth P, Ha P, Tavtigian SV, Teng DH, Bartel PL: Characterization of a carboxy-terminal BRCA1 interacting protein. Oncogene 1998, 17:2279-2285.
8. Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R: The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J Biol Chem 1998, 273:25388-25392.
9. Li S, Chen PL, Subramanian T, Chinnadurai G, Tomlinson G, Osborne CK, Sharp ZD, Lee WH: Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem 1999, 274:11334-11338.
10. Lavialle C, Modjtahedi N, Cassingena R, Brison O: High c-myc amplification level contributes to the tumorigenic phenotype of the breast carcinoma cell line SW 613-S (correction). Oncogene 1988, 3:335-339.
11. Cherif D, Lavialle C, Modjtahedi N, Le Coniat M, Berger R, Brison O: Selection of cells with different chromosomal localizations of the amplified c-myc gene during in vivo and in vitro growth of the breast carcinoma cell line SW 613-S. Chromosoma 1989, 97:327-333.
12. Lavialle C, Modjtahedi N, Lamonerie T, Frebourg T, Landin RM, Fossar N, Lhomond G, Cassingena R, Brison O: The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review). Anticancer Res 1989, 9:1265-1279.
13. Lamonerie T, Lavialle C, Haddada H, Brison O: IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line. Int J Cancer 1995, 61:587-592.
14. Donzelli M, Bernardi R, Negri C, Prosperi E, Padovan L, Lavialle C, Brison O, Scovassi I: Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the cmyc gene. Oncogene 1999, 18:439-448.
15. Lavialle C, Modjtahedi N, Cassingena R, Brison O: High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S. Oncogene 1988, 3:335-339.
16. Modjtahedi N, Lavialle C, Poupon MF, Landin RM, Cassingena R, Monier R, Brison O: Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line. Cancer Res 1985, 45:4372-4379.
17. Modjtahedi N, Frebourg T, Fossar N, Lavialle C, Cremisi C, Brison O: Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW 613-S human colon carcinoma cell line. Exp Cell Res 1992, 201:74-82.
18. Modjtahedi N, Haddada H, Lavialle C, Lazar E, Lamonerie T, Brison O: TGF-alpha production correlates with tumorigenicity in clones of the SW613-S human colon carcinoma cell line. Int J Cancer 1992, 52:483-490.
19. Lamonerie T, Lavialle C, de Galle B, Binoux M, Brison O: Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line. Exp Cell Res 1995, 216:342-351.
20. Galdemard C, Brison O, Lavialle C: The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line. Oncogene 1995, 10:2331-2342.
21. Gunther M, Frebourg T, Laithier M, Fossar N, Bouziane-Ouartini M, Lavialle C, Brison O: An Sp1 binding site and the minimal promoter contribute to overexpression of the cytokeratin 18 gene in tumorigenic clones relative to that in nontumorigenic clones of a human carcinoma cell line. Mol Cell Biol 1995, 15:2490-2499.
22. Prochasson P, Gunther M, Laithier M, Fossar N, Lavialle C, Brison O: Transcriptional mechanisms responsible for the overexpression of the keratin 18 gene in cells of a human colon carcinoma cell line. Exp Cell Res 1999, 248:243-259.
23. Prochasson P, Delouis C, Brison O: Transcriptional deregulation of the keratin 18 gene in human colon carcinoma cells results from an altered acetylation mechanism. Nucleic Acids Res 2002, 30:3312-3322.
24. Sang N, Caro J, Giordano A: Adenoviral E1A: everlasting tool, versatile applications, continuous contributions and new hypotheses. Front Biosci 2002, 7:d407-d413.
25. Quinlan MP, Whyte P, Grodzicker T: Growth factor induction by the adenovirus type 5 E1A 12S protein is required for immortalization of primary epithelial cells. Mol Cell Biol 1988, 8:3191-3203.
26. Sum EY, Peng B, Yu X, Chen J, Byrne J, Lindeman GJ, Visvader JE: The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. J Biol Chem 2002, 277:7849-7856.
27. Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM, Parvin JD: BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A 1997, 94:5605-5610.
28. Chiba N, Parvin JD: The BRCA1 and BARD1 association with the RNA polymerase II holoenzyme. Cancer Res 2002, 62:4222-4228.
29. Avvakumov N, Kajon AE, Hoeben RC, Mymryk JS: Comprehensive sequence analysis of the E1A proteins of human and simian adenoviruses. Virology 2004, 329:477-492.
30. Boyd JM, Loewenstein PM, Tang Qq QQ, Yu L, Green M: Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation. J Virol 2002, 76:1461-1474.
31. Wang HG, Rikitake Y, Carter MC, Yaciuk P, Abraham SE, Zerler B, Moran E: Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol 1993, 67:476-488.
32. Reid JL, Bannister AJ, Zegerman P, Martinez-Balbas MA, Kouzarides T: E1A directly binds and regulates the P/CAF acetyltransferase. EMBO J 1998, 17:4469-4477.
33. Chakravarti D, Ogryzko V, Kao HY, Nash A, Chen H, Nakatani Y, Evans RM: A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 1999, 96:393-403.
34. Gedrich RW, Bayley ST, Engel DA: Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation. J Virol 1992, 66:5849-5859.
35. Lipinski KS, Esche H, Brockmann D: Amino acids 1-29 of the adenovirus serotypes 12 and 2 E1A proteins interact with rap30 (TF(II)F) and TBP in vitro. Virus Res 1998, 54:99-106.
36. Severino A, Baldi A, Cottone G, Han M, Sang N, Giordano A, Mileo AM, Paggi MG, De Luca A: RACK1 is a functional target of the E1A oncoprotein. J Cell Physiol 2004, 199:134-139.
37. Grooteclaes M, Deveraux Q, Hildebrand J, Zhang Q, Goodman RH, Frisch SM: C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc Natl Acad Sci U S A 2003, 100:4568-4573.
38. Schuierer M, Hilger-Eversheim K, Dobner T, Bosserhoff AK, Moser M, Turner J, Crossley M, Buettner R: Induction of AP-2alpha expression by adenoviral infection involves inactivation of the AP-2rep transcriptional corepressor CtBP1. J Biol Chem 2001, 276:27944-27949.
39. Sundqvist A, Bajak E, Kurup SD, Sollerbrant K, Svensson C: Functional knockout of the corepressor CtBP by the second exon of adenovirus E1a relieves repression of transcription. Exp Cell Res 2001, 268:284-293.
40. Li H, Lee TH, Avraham H: A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer. J Biol Chem 2002, 277:20965-20973.
41. Zheng L, Pan H, Li S, Flesken-Nikitin A, Chen PL, Boyer TG, Lee WH: Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol Cell 2000, 6:757-768.
42. Fossar N, Chaouche M, Prochasson P, Rousset M, Brison O: Deregulated expression of the keratin 18 gene in human colon carcinoma cells. Somat Cell Mol Genet 1999, 25:223-235.
43. Choi CH, Hiromura M, Usheva A: Transcription factor IIB acetylates itself to regulate transcription. Nature 2003, 424:965-969.
44. Choi CH, Burton ZF, Usheva A: Auto-acetylation of transcription factors as a control mechanism in gene expression. Cell Cycle 2004, 3:114-115.
45. Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM: The p400 complex is an essential E1A transformation target. Cell 2001, 106:297-307.
46. Magnard C, Bachelier R, Vincent A, Jaquinod M, Kieffer S, Lenoir GM, Venezia ND: BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains. Oncogene 2002, 21:6729-6739.
47. Speicher DW: Electrophoresis. In Current Protocols in Protein Science Edited by: Coligan JE, Dunn BM, Ploegh HL, Speicher DW and Wingfield PT. New York, John Wiley & Sons; 1999:10.0.1-10.13.16.
48. Zhang CL, McKinsey TA, Lu JR, Olson EN: Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J Biol Chem 2001, 276:35-39.